Prescription Brands

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Prescription stem cell therapy originally approved in Europe for treating complex perianal fistulas in adult Crohn's disease patients, developed by TiGenix and acquired by Takeda.

Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.

Prescription COX-2 inhibitor anti-inflammatory medication for treating arthritis pain, originally developed by G.D. Searle & Company and now marketed by Pfizer.

Prescription immunosuppressant medication (mycophenolate mofetil) for preventing organ rejection in transplant recipients, originally developed by Syntex Laboratories and now marketed by Roche.

Prescription smoking cessation medication (varenicline) developed by Pfizer, FDA-approved in 2006.

American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.

Prescription medication for treating hepatic veno-occlusive disease (sinusoidal obstruction syndrome) following hematopoietic stem-cell transplantation, marketed by Jazz Pharmaceuticals.

Prescription proton pump inhibitor (dexlansoprazole) for treating GERD and erosive esophagitis, manufactured by Takeda Pharmaceutical Company.

Prescription antifungal medication (fluconazole) for treating candidiasis, cryptococcal meningitis, and other fungal infections. Developed by Pfizer, FDA-approved in 1990.

Prescription immunosuppressant medication for treating relapsing-remitting multiple sclerosis, manufactured and marketed by Novartis.

Prescription antiretroviral medication for treating HIV infection by inhibiting integrase enzyme, manufactured and marketed by Merck & Co.

Prescription diabetes medication for treating type 2 diabetes by increasing insulin secretion, manufactured and marketed by Merck & Co.

Pfizer's brand name for atorvastatin, the world's best-selling prescription drug from 1996 to 2012, generating over $125 billion in cumulative sales as a cholesterol-lowering statin medication.

Prescription calcium channel blocker medication for treating high blood pressure and angina, manufactured and marketed by Pfizer.

Clopidogrel antiplatelet medication co-developed by Sanofi and Bristol-Myers Squibb, FDA approved in 1997, that became the world's second best-selling drug before its patent expired in May 2012.

Prescription medication for treating male pattern baldness by inhibiting hair loss, manufactured and marketed by Merck & Co.

Prescription medication for treating asthma and allergies by reducing inflammation in the airways, manufactured and marketed by Merck & Co.

Prescription oncology medication for treating chronic myeloid leukemia, owned by Novartis, facing generic competition after its US patent expired in January 2024, with nilotinib generics now available in the market.

Prescription combination medication for treating high blood pressure, manufactured and marketed by Merck & Co.

Pfizer's brand name for sildenafil, the first oral erectile dysfunction treatment approved by the FDA in 1998, now owned by Viatris following the 2020 Upjohn spinoff and Mylan merger.